We have established ourselves as world market leader in the development and marketing of analgesics for the treatment of moderate to severe pain. Our product range covers immediate and controlled release analgesics used at step 2 and 3 of the WHO analgesic ladder. We were the first to introduce a controlled release morphine tablet followed by other controlled release forms. Our opioid analgesics, including oxycodone, have become the worldwide reference products for relieving chronic moderate to severe pain caused by cancer but also other, non-malignant, conditions.